Detalhe da pesquisa
1.
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.
Diabetol Metab Syndr
; 16(1): 23, 2024 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38238868
2.
2022: Position of Brazilian Diabetes Society on exercise recommendations for people with type 1 and type 2 diabetes.
Diabetol Metab Syndr
; 15(1): 2, 2023 Jan 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36593495
3.
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes.
Diabetol Metab Syndr
; 15(1): 160, 2023 Jul 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37468901
4.
The 2021-2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice.
Diabetol Metab Syndr
; 14(1): 189, 2022 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36510287
5.
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.
Diabetol Metab Syndr
; 12: 60, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32684985
6.
Dipeptidyl Peptidase 4 Activity Is Related to Body Composition, Measures of Adiposity, and Insulin Resistance in Subjects with Excessive Adiposity and Different Degrees of Glucose Tolerance.
J Diabetes Res
; 2019: 5238013, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30886868
7.
Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunctionassociated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.
Diabetol Metab Syndr
; 16(1): 54, 2024 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38419114
8.
Dipeptidyl peptidase 4 (DPP4), adipose inflammation, and insulin resistance: is it time to look to the hepatocyte?
Hepatobiliary Surg Nutr
; 7(6): 499-500, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30652100